IDEAS home Printed from https://ideas.repec.org/a/spr/patien/v18y2025i6d10.1007_s40271-025-00747-5.html
   My bibliography  Save this article

Considering Clinical Implementation of Polygenic Scores in Hereditary Cancer Risk Assessment: Recipients’ Perspectives on Influencing Factors and Strategies

Author

Listed:
  • Rebecca Purvis

    (The University of Melbourne
    Peter MacCallum Cancer Centre and The Royal Melbourne Hospital)

  • Natalie Taylor

    (University of New South Wales)

  • Paul James

    (The University of Melbourne
    Peter MacCallum Cancer Centre and The Royal Melbourne Hospital)

  • Mary-Anne Young

    (Garvan Institute of Medical Research
    St Vincent’s Clinical Campus)

  • Laura E. Forrest

    (The University of Melbourne
    Peter MacCallum Cancer Centre and The Royal Melbourne Hospital)

Abstract

Background Polygenic scores (PGS) capture a proportion of the genomic liability for cancer in unselected and high-risk cohorts, with meaningful application in improving risk-stratified screening and management. However, there are significant evidence gaps regarding future clinical implementation. Despite being key interest-holders, recipient views are underrepresented. The objective of this study was to explore recipients’ views on the clinical implementation of PGS for hereditary cancer risk assessment in Australian cancer genetics clinics. Methods Three video-conferenced focus groups were conducted with recipients who had been given their breast and ovarian cancer PGS through the PRiMo trial. Nominal Group Technique was used to enable evaluation of implementation determinants and strategies, and priority setting. Descriptive and deductive content analyses were conducted utilising the Consolidated Framework for Implementation Research and the Expert Recommendations for Implementing Change compilation of facilitative strategies. Results Participants (N = 10) were female, with an average age of 36 years (range 18–70 years). Of these, 50% (N = 5) experienced a change in their hereditary cancer risk assessment due to their PGS. Participants prioritised the positive value and impact of PGS, and the behavioural characteristics of recipients, notably their knowledge and expectations of PGS and cancer genetics clinics, as major determinants of implementation success. Implementation strategies that prepared and supported recipients to access, engage, and use PGS were emphasised, with a focus on a clear results report, educational resources, in-clinic resources, and delivery of ongoing good clinical follow-up. Conclusion Evidence-based strategies should be deployed to address recipients’ priority barriers to the clinical implementation of PGS for hereditary cancer risk assessment. Centralising recipient voices in implementation design will improve effectiveness and success.

Suggested Citation

  • Rebecca Purvis & Natalie Taylor & Paul James & Mary-Anne Young & Laura E. Forrest, 2025. "Considering Clinical Implementation of Polygenic Scores in Hereditary Cancer Risk Assessment: Recipients’ Perspectives on Influencing Factors and Strategies," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 18(6), pages 673-686, November.
  • Handle: RePEc:spr:patien:v:18:y:2025:i:6:d:10.1007_s40271-025-00747-5
    DOI: 10.1007/s40271-025-00747-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40271-025-00747-5
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40271-025-00747-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to

    for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:patien:v:18:y:2025:i:6:d:10.1007_s40271-025-00747-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.